Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - Nasdaq - CH1134239669 - Common Stock

20.5  +0.16 (+0.79%)

Fundamental Rating

6

Taking everything into account, SRAD scores 6 out of 10 in our fundamental rating. SRAD was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of SRAD get a neutral evaluation. Nothing too spectacular is happening here. SRAD is valued quite expensive, but it does show an excellent growth. These ratings could make SRAD a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SRAD had positive earnings in the past year.
SRAD had a positive operating cash flow in the past year.
SRAD had positive earnings in each of the past 5 years.
SRAD had a positive operating cash flow in each of the past 5 years.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

1.2 Ratios

SRAD has a Return On Assets of 2.58%. This is comparable to the rest of the industry: SRAD outperforms 54.20% of its industry peers.
The Return On Equity of SRAD (6.43%) is better than 61.07% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.84%, SRAD is in line with its industry, outperforming 41.22% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SRAD is significantly below the industry average of 10.54%.
The 3 year average ROIC (2.22%) for SRAD is below the current ROIC(3.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.58%
ROE 6.43%
ROIC 3.84%
ROA(3y)1.01%
ROA(5y)1.25%
ROE(3y)2.38%
ROE(5y)4.74%
ROIC(3y)2.22%
ROIC(5y)3.49%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

SRAD's Profit Margin of 5.57% is fine compared to the rest of the industry. SRAD outperforms 61.07% of its industry peers.
In the last couple of years the Profit Margin of SRAD has grown nicely.
SRAD has a Operating Margin of 10.51%. This is comparable to the rest of the industry: SRAD outperforms 54.20% of its industry peers.
In the last couple of years the Operating Margin of SRAD has declined.
Looking at the Gross Margin, with a value of 73.72%, SRAD belongs to the top of the industry, outperforming 90.08% of the companies in the same industry.
SRAD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.51%
PM (TTM) 5.57%
GM 73.72%
OM growth 3Y-11.88%
OM growth 5YN/A
PM growth 3Y1.7%
PM growth 5YN/A
GM growth 3Y-0.6%
GM growth 5YN/A
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 20 40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRAD is destroying value.
Compared to 1 year ago, SRAD has more shares outstanding
Compared to 1 year ago, SRAD has a worse debt to assets ratio.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 3.44 indicates that SRAD is not in any danger for bankruptcy at the moment.
SRAD has a better Altman-Z score (3.44) than 78.63% of its industry peers.
The Debt to FCF ratio of SRAD is 0.36, which is an excellent value as it means it would take SRAD, only 0.36 years of fcf income to pay off all of its debts.
SRAD has a Debt to FCF ratio of 0.36. This is amongst the best in the industry. SRAD outperforms 93.89% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that SRAD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, SRAD belongs to the top of the industry, outperforming 86.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.36
Altman-Z 3.44
ROIC/WACC0.73
WACC5.27%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

SRAD has a Current Ratio of 1.53. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.53, SRAD is doing good in the industry, outperforming 72.52% of the companies in the same industry.
A Quick Ratio of 1.53 indicates that SRAD should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.53, SRAD is doing good in the industry, outperforming 75.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 575.00% over the past year.
Measured over the past years, SRAD shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.72% on average per year.
Looking at the last year, SRAD shows a very strong growth in Revenue. The Revenue has grown by 26.56%.
SRAD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.42% yearly.
EPS 1Y (TTM)575%
EPS 3Y30.72%
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)26.56%
Revenue growth 3Y29.42%
Revenue growth 5YN/A
Sales Q2Q%26.93%

3.2 Future

SRAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.63% yearly.
Based on estimates for the next years, SRAD will show a quite strong growth in Revenue. The Revenue will grow by 15.25% on average per year.
EPS Next Y-2.2%
EPS Next 2Y32.8%
EPS Next 3Y38.55%
EPS Next 5Y41.63%
Revenue Next Year24.88%
Revenue Next 2Y19.18%
Revenue Next 3Y16.21%
Revenue Next 5Y15.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 102.50 indicates a quite expensive valuation of SRAD.
Based on the Price/Earnings ratio, SRAD is valued a bit more expensive than the industry average as 64.89% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 28.29. SRAD is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 74.82, which means the current valuation is very expensive for SRAD.
Based on the Price/Forward Earnings ratio, SRAD is valued a bit more expensive than 63.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, SRAD is valued quite expensively.
Industry RankSector Rank
PE 102.5
Fwd PE 74.82
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

SRAD's Enterprise Value to EBITDA is on the same level as the industry average.
SRAD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 45.3
EV/EBITDA 14.08
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

The decent profitability rating of SRAD may justify a higher PE ratio.
A more expensive valuation may be justified as SRAD's earnings are expected to grow with 38.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.8%
EPS Next 3Y38.55%

More info and screens

0

5. Dividend

5.1 Amount

SRAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (1/22/2025, 11:33:19 AM)

20.5

+0.16 (+0.79%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners82.29%
Inst Owner Change0.03%
Ins Owners2.22%
Ins Owner ChangeN/A
Market Cap6.11B
Analysts80
Price Target17.98 (-12.29%)
Short Float %2.46%
Short Ratio6.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)89.2%
Min EPS beat(2)-100%
Max EPS beat(2)278.4%
EPS beat(4)2
Avg EPS beat(4)42.11%
Min EPS beat(4)-100%
Max EPS beat(4)278.4%
EPS beat(8)2
Avg EPS beat(8)-48.13%
EPS beat(12)6
Avg EPS beat(12)3.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.13%
Min Revenue beat(2)3.38%
Max Revenue beat(2)4.89%
Revenue beat(4)3
Avg Revenue beat(4)3.3%
Min Revenue beat(4)-0.6%
Max Revenue beat(4)5.54%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)8
Avg Revenue beat(12)1.05%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.47%
PT rev (3m)17.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-46.71%
EPS NY rev (1m)0%
EPS NY rev (3m)110.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.64%
Valuation
Industry RankSector Rank
PE 102.5
Fwd PE 74.82
P/S 5.61
P/FCF 45.3
P/OCF 18.27
P/B 6.47
P/tB N/A
EV/EBITDA 14.08
EPS(TTM)0.2
EY0.98%
EPS(NY)0.27
Fwd EY1.34%
FCF(TTM)0.45
FCFY2.21%
OCF(TTM)1.12
OCFY5.47%
SpS3.65
BVpS3.17
TBVpS-2.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.58%
ROE 6.43%
ROCE 5.8%
ROIC 3.84%
ROICexc 4.76%
ROICexgc N/A
OM 10.51%
PM (TTM) 5.57%
GM 73.72%
FCFM 12.38%
ROA(3y)1.01%
ROA(5y)1.25%
ROE(3y)2.38%
ROE(5y)4.74%
ROIC(3y)2.22%
ROIC(5y)3.49%
ROICexc(3y)3.29%
ROICexc(5y)5.26%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.36%
ROCE(5y)5.28%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-30.22%
ROICexc growth 5YN/A
OM growth 3Y-11.88%
OM growth 5YN/A
PM growth 3Y1.7%
PM growth 5YN/A
GM growth 3Y-0.6%
GM growth 5YN/A
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.36
Debt/EBITDA 0.09
Cap/Depr 68.28%
Cap/Sales 18.33%
Interest Coverage 1.52
Cash Conversion 82.21%
Profit Quality 222.12%
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 3.44
F-Score5
WACC5.27%
ROIC/WACC0.73
Cap/Depr(3y)93.93%
Cap/Depr(5y)83.46%
Cap/Sales(3y)22.8%
Cap/Sales(5y)23.49%
Profit Quality(3y)76.66%
Profit Quality(5y)202.93%
High Growth Momentum
Growth
EPS 1Y (TTM)575%
EPS 3Y30.72%
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y-2.2%
EPS Next 2Y32.8%
EPS Next 3Y38.55%
EPS Next 5Y41.63%
Revenue 1Y (TTM)26.56%
Revenue growth 3Y29.42%
Revenue growth 5YN/A
Sales Q2Q%26.93%
Revenue Next Year24.88%
Revenue Next 2Y19.18%
Revenue Next 3Y16.21%
Revenue Next 5Y15.25%
EBIT growth 1Y78.12%
EBIT growth 3Y14.04%
EBIT growth 5YN/A
EBIT Next Year192.32%
EBIT Next 3Y64.29%
EBIT Next 5Y45.48%
FCF growth 1Y974.26%
FCF growth 3Y0.62%
FCF growth 5YN/A
OCF growth 1Y108.72%
OCF growth 3Y19.57%
OCF growth 5YN/A